Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1998-1-23
|
pubmed:abstractText |
In a serum-free liquid culture, thrombopoietin (TPO) selectively stimulated the growth of megakaryocytic cells from CD34-positive cord blood cells. Using these cultured cells, we investigated cytokine production by human megakaryocytes. Day 10 megakaryocytes (2 x 10(5)) secreted > 1000 pg/ml of interleukin (IL)-8, in contrast to small amounts of IL-1beta and IL-6. A time-course study showed that the IL-8 production of megakaryocytes occurred at the late phase of the culture period. The megakaryocyte-conditioned medium had the chemotactic potential of polymorphonuclear leucocytes, which was abrogated by the addition of anti-IL-8 antibody, suggesting the secretion of biologically active IL-8. The combination of TPO and IL-1alpha was required for a significant augmentation of the IL-8 secretion. Direct evidence for IL-8 synthesis in megakaryocytes was provided by reverse transcription-polymerase chain reaction on purified CD41b+ cells and by the detection of intracellular IL-8 in CD41b+ cells. These results suggest that TPO stimulates not only the proliferation and differentiation of the progenitors capable of megakaryocytic lineage expression but also IL-8 release by the megakaryocytic cells with the aid of IL-1.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, Serum-Free,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-8,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Thrombopoietin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0007-1048
|
pubmed:author |
pubmed-author:HiguchiTT,
pubmed-author:IkedaMM,
pubmed-author:ItoSS,
pubmed-author:KatoTT,
pubmed-author:KikuchiTT,
pubmed-author:KoikeKK,
pubmed-author:KomiyamaAA,
pubmed-author:MiyazakiHH,
pubmed-author:MwamtemiH HHH,
pubmed-author:OkumuraNN,
pubmed-author:SasakiYY,
pubmed-author:SawaiNN,
pubmed-author:ShioharaMM,
pubmed-author:TakeuchiKK,
pubmed-author:YamadaMM,
pubmed-author:YamagamiOO,
pubmed-author:YasuiKK
|
pubmed:issnType |
Print
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
509-16
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9401057-Cells, Cultured,
pubmed-meshheading:9401057-Chemotaxis,
pubmed-meshheading:9401057-Culture Media, Serum-Free,
pubmed-meshheading:9401057-Fetal Blood,
pubmed-meshheading:9401057-Humans,
pubmed-meshheading:9401057-Interleukin-1,
pubmed-meshheading:9401057-Interleukin-8,
pubmed-meshheading:9401057-Megakaryocytes,
pubmed-meshheading:9401057-Neutrophils,
pubmed-meshheading:9401057-Polymerase Chain Reaction,
pubmed-meshheading:9401057-RNA, Messenger,
pubmed-meshheading:9401057-Thrombopoietin
|
pubmed:year |
1997
|
pubmed:articleTitle |
Megakaryocytes derived from CD34-positive cord blood cells produce interleukin-8.
|
pubmed:affiliation |
Department of Paediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
|
pubmed:publicationType |
Journal Article
|